Fig. 7From: Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagyCaspase-3 staining of U87 cells treated with Ad/IL-24. A-EÂ U87 cells were treated with concentrations of Ad/IL-24 (MOI: 3, 5, and 10) for 48 h, after that expose to secondary antibody staining and analyzed by flow cytometry. Un-treated cells and Ad/GFP were considered control groups. FÂ The total percentage of apoptotic cells was stained with Caspase-3. ** (P < 0.01), ***(P < 0.001), ****(P<0.0001)Back to article page